Edition:
India

Bio-Techne Corp (TECH.OQ)

TECH.OQ on NASDAQ Stock Exchange Global Select Market

152.78USD
20 Apr 2018
Change (% chg)

$0.59 (+0.39%)
Prev Close
$152.19
Open
$152.19
Day's High
$153.83
Day's Low
$152.19
Volume
71,030
Avg. Vol
71,737
52-wk High
$153.83
52-wk Low
$101.33

Chart for

About

Bio-Techne Corporation develops, manufactures and sells biotechnology reagents and instruments for the research and clinical diagnostic markets. The Company operates through three segments: Biotechnology, Clinical Controls and Protein Platforms. The Biotechnology segment develops, manufactures and sells biotechnology research... (more)

Overall

Beta: 0.72
Market Cap(Mil.): $4,582.91
Shares Outstanding(Mil.): 37.39
Dividend: 0.32
Yield (%): 1.04

Financials

BRIEF-Bio-Techne Q2 GAAP Earnings Per Share $1.29

* QTRLY GAAP EPS SAW A ONE-TIME BENEFIT OF $0.94 FROM TAX REFORM Source text for Eikon: Further company coverage:

06 Feb 2018

BRIEF-Bio-Techne Acquires Atlanta Biologicals Inc

* BIO-TECHNE CORP - ‍TRANSACTION IS FINANCED THROUGH AVAILABLE CASH ON HAND​

03 Jan 2018

BRIEF-Women In Bio announces that Alpna Seth joins Bio-Techne's board

* Women In Bio announces that Alpna Seth joins Bio-Techne's board of directors Source text for Eikon:

07 Nov 2017

BRIEF-Bio-Techne releases Q1 adjusted earnings per share $0.90

* Q1 earnings per share view $0.88 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

31 Oct 2017

BRIEF-Bio-Techne adds two new directors to its board

* Bio-Techne adds two new directors to its board Source text for Eikon: Further company coverage:

27 Oct 2017

Earnings vs. Estimates